Citron's Left reiterates belief AbbVie shares will fall sharplyShort-seller Andrew Left's Citron Research expanded on his prediction that U.S. drugmaker AbbVie Inc's stock would fall to $60 a share, arguing that new regulations to speed biosimilar drugs to the market and reform rebates w…Read More
Scooter companies ride high on hope and hypeSegway-Ninebot Group, a Beijing-based manufacturer of electric scooters, rolled into Los Angeles this week hoping to bolster its position as the main supplier for a new wave of well-funded scooter-rental startups and offer a …Read More
0 comments:
Post a Comment